Search Results - "Bach‐Rojecky, L."
-
1
Role of central versus peripheral opioid system in antinociceptive and anti‐inflammatory effect of botulinum toxin type A in trigeminal region
Published in European journal of pain (01-03-2018)“…Background Although botulinum toxin type A (BT‐A) is approved for chronic migraine treatment, its site and mechanism of action are still elusive. Recently our…”
Get full text
Journal Article -
2
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
Published in Neuroscience (14-07-2011)“…Abstract Botulinum toxin A (BTX-A) is approved for treatment of different cholinergic hyperactivity disorders, and, recently, migraine headache. Although…”
Get full text
Journal Article -
3
A century of phage therapy: from novel discoveries about the past to the challenges of the today
Published in Pharmazie (01-10-2021)“…The discovery of bacterial viruses able to kill bacteria, named bacteriophages (phages), more than a century ago, contributed to combating bacterial infections…”
Get more information
Journal Article -
4
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
Published in Neuropharmacology (01-07-2013)“…Botulinum toxin A (BTX-A) is approved for treatment of chronic migraine and has been investigated in various other painful conditions. Recent evidence…”
Get full text
Journal Article -
5
Association of antinociceptive action of botulinum toxin type A with GABA-A receptor
Published in Journal of Neural Transmission (01-06-2014)“…The mechanism of botulinum toxin type A (BTX-A) antinociceptive action in the central nervous system is little known. The potential interaction between BTX-A…”
Get full text
Journal Article -
6
Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain
Published in Journal of Neural Transmission (01-12-2016)“…“Mirror pain” or mirror-image pain (MP) is pain opposite to the side of injury. Mechanism and frequency in humans are not known. There is no consent on…”
Get full text
Journal Article -
7
137 Antinociceptive effect of botulinum toxin type A in experimental diabetic neuropathy
Published in European journal of pain (01-06-2007)Get full text
Journal Article -
8
Botulinum toxin type A in experimental neuropathic pain
Published in Journal of Neural Transmission (01-02-2005)“…A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic…”
Get full text
Journal Article -
9
Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus
Published in Journal of neural transmission. Supplementum (2007)“…It is believed that oxidative stress plays a central role in the pathogenesis of metabolic diseases like diabetes mellitus (DM) and its complications (like…”
Get more information
Journal Article -
10
3.310 THE PUZZLE OF BOTULINUM TOXIN AND PAIN
Published in Parkinsonism & related disorders (2012)Get full text
Journal Article -
11
Central origin of the antinociceptive action of botulinum toxin type A
Published in Pharmacology, biochemistry and behavior (01-12-2009)“…Here we provide behavioural evidence for an axonal transport and the central origin of the antinociceptive effect of botulinum toxin type A (BTX-A). In rats we…”
Get full text
Journal Article -
12
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection
Published in European journal of pharmacology (10-05-2010)“…We investigated antinociceptive activity of botulinum toxin type A (BTX-A) in a model of diabetic neuropathic pain in rats. Male Wistar rats were made diabetic…”
Get full text
Journal Article -
13
Botulinum toxin: Central or peripheral mechanism of action?
Published in Parkinsonism & related disorders (01-01-2018)Get full text
Journal Article -
14
Involvement of I14-opioid receptors in antinociceptive action of botulinum toxin type A
Published in Neuropharmacology (01-07-2013)“…Botulinum toxin A (BTX-A) is approved for treatment of chronic migraine and has been investigated in various other painful conditions. Recent evidence…”
Get full text
Journal Article -
15
Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids
Published in Personalized medicine (01-03-2019)“…Successful pain management requires the delivery of analgesia with minimal risk of adverse drug reactions. Nonsteroidal anti-inflammatory drugs and opioids…”
Get more information
Journal Article -
16
Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain
Published in Croatian medical journal (01-04-2005)“…To test antinociceptive properties of botulinum toxin type A (BTX-A) in rats with carrageenan- and capsaicin-induced pain and inflammation. Pain was provoked…”
Get full text
Journal Article -
17
Neuroscience.: behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
Published in Croatian medical journal (01-10-2011)Get full text
Journal Article